BELLETTI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 7.523
EU - Europa 4.545
AS - Asia 1.015
SA - Sud America 22
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 13.134
Nazione #
US - Stati Uniti d'America 7.498
GB - Regno Unito 1.699
IT - Italia 1.467
SE - Svezia 392
CN - Cina 367
DE - Germania 260
TR - Turchia 246
HK - Hong Kong 228
UA - Ucraina 214
FI - Finlandia 119
FR - Francia 118
BG - Bulgaria 83
IN - India 50
KR - Corea 29
IR - Iran 26
BE - Belgio 25
RU - Federazione Russa 24
IE - Irlanda 23
RO - Romania 22
CA - Canada 20
NL - Olanda 18
CH - Svizzera 15
ES - Italia 12
SG - Singapore 12
IL - Israele 11
GR - Grecia 10
LT - Lituania 10
VN - Vietnam 10
EU - Europa 9
JP - Giappone 8
PL - Polonia 8
PT - Portogallo 8
HU - Ungheria 6
BR - Brasile 5
CL - Cile 5
CO - Colombia 5
BZ - Belize 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
PE - Perù 4
TW - Taiwan 4
AU - Australia 3
EG - Egitto 3
MY - Malesia 3
PK - Pakistan 3
SN - Senegal 3
YE - Yemen 3
AR - Argentina 2
BY - Bielorussia 2
DK - Danimarca 2
NG - Nigeria 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BO - Bolivia 1
DZ - Algeria 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 13.134
Città #
Southend 1.526
Fairfield 1.077
Woodbridge 706
Chandler 648
Ashburn 605
Jacksonville 454
Houston 445
Seattle 434
Wilmington 413
Dearborn 386
Ann Arbor 379
Cambridge 366
Nyköping 282
Modena 228
Hong Kong 227
Beijing 160
Izmir 157
Princeton 91
San Diego 81
Sofia 81
Eugene 80
Milan 73
Redwood City 53
New York 52
Rome 51
Fremont 48
Falls Church 47
Helsinki 45
London 43
Bologna 36
Bremen 34
Como 27
Napoli 26
Brussels 22
Des Moines 22
San Giuliano Milanese 22
Tulare 21
Florence 19
Dublin 18
Naples 16
Norwalk 16
Hefei 15
Kocaeli 15
Palermo 15
Parma 13
Genoa 12
Perugia 12
Bari 11
Catania 11
Phoenix 11
Shanghai 11
Halifax 10
Kunming 10
Nanjing 10
Reggio Emilia 10
Turin 10
Boardman 9
Chennai 9
Frankfurt am Main 9
Los Angeles 9
Pescara 9
Ferrara 8
Guangzhou 8
Indiana 8
Mountain View 8
Saint Petersburg 8
Castelnuovo Di Porto 7
Dongguan 7
Gandhinagar 7
Hounslow 7
Jinan 7
Rende 7
Salerno 7
Bengaluru 6
Dong Ket 6
Padova 6
Prescot 6
Saarbrücken 6
Venezia 6
Washington 6
Catanzaro 5
Changsha 5
Founex 5
Indianapolis 5
Kilburn 5
Lequile 5
Paris 5
Pavia 5
Santiago 5
Toronto 5
Wuhan 5
Auburn Hills 4
Belize City 4
Binyamina 4
Brescia 4
Chengdu 4
Chicago 4
Chiswick 4
Dallas 4
Groningen 4
Totale 9.960
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 350
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 300
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 276
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 268
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 258
Protein corona and nanoparticles: How can we investigate on? 243
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 236
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 234
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 231
Nanoparticle transport across the blood brain barrier 227
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 226
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 224
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 222
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 222
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 219
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 218
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 217
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 213
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 203
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 200
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 199
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 199
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 195
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 194
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 190
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 187
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 186
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 186
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 186
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 181
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 180
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 180
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 179
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 178
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 178
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 177
Functionalization of liposomes: microscopical methods for preformulative screening 174
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 174
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 172
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 170
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 168
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 167
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 167
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 162
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 159
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 155
Nanomedicine: the future for advancing medicine and neuroscience 153
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 150
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 149
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 147
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 146
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 143
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 138
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 135
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 134
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 134
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 134
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 128
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 126
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 126
Immunonanosystems to CNS pathologies: State of the art 125
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 125
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 125
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 122
Nanotechnology and Central Nervous System Drug Delivery 107
Leptin-conjugated nanoparticles as drug delivery system to the brain 106
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 102
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 100
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 100
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 100
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 91
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 89
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 88
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 81
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 80
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 79
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 79
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 74
Nanotechnology in medicine: therapeutic strategies in neurological disorders 69
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 68
Nanomedicine in neurodegenerative disorders: Understanding the journey 58
Totale 13.341
Categoria #
all - tutte 43.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019703 0 0 0 0 0 0 0 0 0 0 328 375
2019/20203.067 172 148 88 176 353 423 519 363 413 119 213 80
2020/20212.600 363 92 174 225 219 174 199 307 113 494 144 96
2021/20221.693 100 156 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.202 72 66 91 98 298 139 145 172 37 39 45 0
Totale 13.341